From a clinical perspective, our findings suggest that serum KL measurement – currently used in aging and chronic kidney disease research[35,36] – should standardize caffeine abstinence (e.g., 24 hours prior to blood sampling), especially in populations with high caffeine intake (e.g., <60 years, overweight/obese). The gene discussed is KL; the disease is chronic kidney disease.